KOE · 216080.KQ
JETEMA, Co., Ltd.
₩5,860-₩60 (-1.01%)
JETEMA, Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.05% below the high.
Loading market information…
KOE · 461030.KQ · KRW
Stock price
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
IMBdx’s quoted price sits in the lower half of its reported 52-week range, 81.51% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:28 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩5,860-₩60 (-1.01%)
JETEMA, Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.05% below the high.
₩5,260-₩90 (-1.68%)
EASY BIO,Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.55% below the high.
₩10,900-₩50 (-0.46%)
Macrogen, Inc.’s quoted price sits in the lower half of its reported 52-week range, 47.85% below the high.
₩3,050+₩80 (+2.69%)
MedPacto, Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.74% below the high.
₩2,790-₩85 (-2.96%)
iNtRON Biotechnology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.2% below the high.
₩841-₩36 (-4.1%)
CG Invites Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 49.55% below the high.
₩916+₩10 (+1.1%)
Amicogen, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.77% below the high.
₩4,675-₩185 (-3.81%)
Encell Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 77.68% below the high.
